Inter Pharma Public Company Limited (IP) Stock Statistics & Valuation Metrics

Inter Pharma Public Company Limited has a market cap or net worth of THB 2.92B. The enterprise value is THB 3.07B.

Market Cap

THB 2.92B

Enterprise Value

THB 3.07B

Inter Pharma Public Company Limited has 605,344,500 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

605,344,500

Owned by Insiders

―

Owned by Institutions

―

Inter Pharma Public Company Limited’s return on equity (ROE) is 0.06 and return on invested capital (ROIC) is 4.84%.

Return on Equity (ROE)

0.06

Return on Assets (ROA)

0.04

Return on Invested Capital (ROIC)

4.84%

Return on Capital Employed (ROCE)

0.07

Revenue Per Employee

34.27M

Profits Per Employee

1.91M

Employee Count

64

Asset Turnover

0.68

Inventory Turnover

3.83

The current PE Ratio of Inter Pharma Public Company Limited is 21.15. Inter Pharma Public Company Limited’s PEG ratio is 0.23.

PE Ratio

21.15

PS Ratio

1.30

PB Ratio

1.40

Price to FCF

28.82

Price to Operating Cash Flow

12.87

PEG Ratio

0.23

In the last 12 months, Inter Pharma Public Company Limited had revenue of 2.19B and earned 122.38M in profits. Earnings per share was 0.20.

Revenue

2.19B

Gross Profit

820.52M

Operating Income

171.40M

Pretax Income

171.17M

Net Income

122.38M

EBITDA

288.15M

Earnings Per Share (EPS)

0.20

In the last 12 months, operating cash flow was 226.69M and capital expenditures -125.44M, giving a free cash flow of 101.25M billion.

Operating Cash Flow

226.69M

Free Cash Flow

101.25M

Free Cash Flow per Share

0.17

Inter Pharma Public Company Limited pays an annual dividend of ―, resulting in a dividend yield of 1.51%

Dividend Per Share

―

Dividend Yield

1.51%

Payout Ratio

N/A

Free Cash Flow Yield

3.47%

Earnings Yield

4.73%

Beta

0.69

52-Week Price Change

19.90%

50-Day Moving Average

―

200-Day Moving Average

―

Relative Strength Index (RSI)

41.64

Average Volume (3m)

243.30K

Inter Pharma Public Company Limited upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 14, 2026

Next Earnings Date

Nov 17, 2026

Ex-Dividend Date

―

Inter Pharma Public Company Limited as a current ratio of 1.73, with Debt / Equity ratio of 19.47%

Current Ratio

1.73

Quick Ratio

1.17

Debt to Market Cap

0.11

Net Debt to EBITDA

0.42

Interest Coverage Ratio

8.76

In the past 12 months, Inter Pharma Public Company Limited has paid 35.10M in taxes.

Income Tax

35.10M

Effective Tax Rate

0.21

Inter Pharma Public Company Limited EV to EBITDA ratio is 9.13, with an EV/FCF ratio of 30.02.

EV to Sales

1.36

EV to EBITDA

9.13

EV to Free Cash Flow

30.02

EV to Operating Cash Flow

13.41

Inter Pharma Public Company Limited has THB 241.50M in cash and marketable securities with THB 363.25M in debt, giving a net cash position of -THB 121.75M billion.

Cash & Marketable Securities

THB 241.50M

Total Debt

THB 363.25M

Net Cash

-THB 121.75M

Net Cash Per Share

-THB 0.20

Tangible Book Value Per Share

THB 2.57

Gross margin is 42.46%, with operating margin of 9.04%, and net profit margin of 6.15%.

Gross Margin

42.46%

Operating Margin

9.04%

Pretax Margin

8.84%

Net Profit Margin

6.15%

EBITDA Margin

14.84%

EBIT Margin

9.37%

The average price target for Inter Pharma Public Company Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

10.29%

EPS Growth Forecast

91.11%